有前列腺癌病史患者行全髋关节置换术后并发症与费用未增加
基于Medicare标准分析文件,匹配年龄、糖尿病、吸烟、慢性肾病、酒精滥用、慢性肝病和肥胖后,比较有或无前列腺癌病史的骨关节炎患者行全髋关节置换术的90天结局。每组各62571例,有前列腺癌病史组90天肺炎发生率更低(2.68% vs 3.26%;OR 0.82),其他并发症及90天费用与报销均相当,平均报销有病史组14153美元 vs 无病史组14033美元(P=0.114)。
要点
- 有前列腺癌病史患者全髋关节置换术后90天血栓栓塞等并发症与无病史者临床相当。
- 无前列腺癌病史组90天肺炎发生率更高(3.26% vs 2.68%;OR 0.82)。
- 两组90天费用与报销相当,平均报销14153美元 vs 14033美元(P=0.114)。
核心结论
- 在大样本病例对照研究中,有前列腺癌病史患者全髋关节置换术后短期并发症风险未增加,两组90天平均报销相似。
研究设计与样本
- 基于Medicare标准分析文件、通过PearlDiver服务器识别的病例对照研究,比较因骨关节炎行全髋关节置换术的有或无前列腺癌病史患者。
- 两组按年龄、糖尿病、吸烟状态、慢性肾病、酒精滥用、慢性肝病和肥胖进行匹配,匹配后每组各62571例。
- 采用单变量回归(比值比)比较术后90天并发症率。
主要发现
- 无前列腺癌病史组90天肺炎发生率高于有病史组(3.26% vs 2.68%;OR 0.82)。
- 包括血栓栓塞性疾病在内的所有其他并发症在术后90天期间两组临床相当。
- 90天费用与报销两组相当,有前列腺癌病史组平均报销14153美元 vs 无病史组14033美元(P=0.114)。
关键数值与推荐
- 匹配后每组各62571例,总样本125142例。
- 90天肺炎发生率:无前列腺癌病史组3.26% vs 有病史组2.68%(OR 0.82)。
- 90天平均报销:有前列腺癌病史组14153美元 vs 无病史组14033美元(P=0.114)。
临床怎么用
- 原文结论指出有前列腺癌病史患者全髋关节置换术后短期并发症风险未增加,两组90天平均报销相似。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prostate cancer (PCa) is a largely prevalent disease in the United States. Moreover, it is unclear whether the thromboembolic burden of disease remains present after the cancer has been treated and whether such state impacts the short-term outcomes of orthopedic procedures. Therefore, the purpose of this study is to assess 90-day postoperative complications and costs after total hip arthroplasty (THA) for osteoarthritis in patients with a history of PCa. METHODS: Two groups of patients who underwent THA for osteoarthritis in the Medicare Standard Analytical Files were identified through the PearlDiver server. Both groups were matched based on age, diabetes, smoking status, chronic kidney disease, alcohol abuse, chronic liver disease, and obesity in order to create a case-control study comparison. The 90-day complication rates after THA were compared using univariate regressions (odds ratio). We hypothesized that patients with a history of PCa would develop increased rates of thromboembolic complications based on a prolonged procoagulative state. RESULTS: After matching, each group was comprised of 62,571 patients. Our findings identified greater 90-day pneumonia rates for those without a history of PCa (3.26% vs 2.68%; odds ratio, 0.82). All other complications including thromboembolic diseases were clinically comparable in both groups during the 90-day postoperative period. The charges and reimbursements for the 90-day period were also comparable. CONCLUSION: In our large case-control study of 125,142 patients, we found that patients with a history of PCa do not have increased risk of short-term complications after THA and that the mean 90-day reimbursements were similar for both groups at $14,153 for PCa patients and $14,033 for those without (P = .114).
引用
- Rosas S, Tipton S, Luo TD, et al. Complications and Costs Are Not Increased After Total Hip Arthroplasty in Patients With a History of Prostate Cancer. J Arthroplasty. 2019. PMID: 31326242. doi:10.1016/j.arth.2019.06.052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。